Next-Generation Sequencing In-Depth Focus 2016

NGS technologies have been employed in a wide range of areas in drug discovery, including drug target identification, biomarker discovery and biopharmaceutics development. Pushpanathan Muthuirulan of the National Institutes of Health gives us an overview of this in his article in our NGS In-Depth Focus. Meanwhile, the possibilities that RNA-Seq offers in molecular diagnostics and clinical research, as an alternative method to RT-qPCR, are covered in an article by Michael W. Pfaffl at TUM School of Life Sciences.

Next-Generation Sequencing In-Depth Focus 2016

This Next-Generation Sequencing In-Depth Focus is restricted to logged-in members. Login or subscribe free to read it.

2 responses to “Next-Generation Sequencing In-Depth Focus 2016”

  1. Vassilis says:

    please send to me the paper

Leave a Reply

Your email address will not be published. Required fields are marked *

Send this to a friend